Table 1.
Total (%) | Median (Range) | ||
| |||
Male | 18 (53) | ||
| |||
Age at operation (years) (both groups) | 55 (27-71) | ||
| |||
Age at operation (years) (transplant group) | 54 (27-68) | ||
| |||
Age at operation (years) (dialysis group) | 59 (40-71) | ||
| |||
Indication | Discomfort/space | 20 (59) | |
Infection | 12 (36) | ||
Haematuria | 5 (15) | ||
Pain | 8 (24) | ||
Weight loss and cystic content modification | 1 (3) | ||
| |||
Transplant pre-native bilateral nephrectomy | 18 (53) | ||
| |||
Transplant post-bilateral native nephrectomy | 8 (24) | ||
| |||
eGFR pre-nephrectomy (18 patients-transplant group) | 44 (29-73) | ||
| |||
eGFR day 1 post-nephrectomy (18 patients-transplant group) | 45 (27-90) | ||
| |||
Hb pre-native bilateral nephrectomy | 121 (82-150) | ||
| |||
Hb day 1 post-native bilateral nephrectomy | 107 (58-154) | ||
| |||
Transfusion | 14 (42) | ||
| |||
Anti-HLA or DSA level change | 1 (3) | ||
| |||
Length of hospital stay (days) | 9 (6-71) |
DSA: Donor Specific Antibody. HLA: Human Leukocyte Antigen.